A single-shot COVID-19 vaccine is being developed by scientists led by a Beth Israel Deaconess Medical Center immunologist.

Vaccines that might protect against COVID-19 have entered phase 3 trials — the last step before regular approval in humans — in record time, but the virus has moved faster, experts say.

New study finds olfactory support cells, not neurons, are vulnerable to novel coronavirus infection.

New quantum-classical algorithm brings nuclear magnetic resonance readings closer to “near-term” quantum computing.

An initiative seeks to make scientists and their work more relatable to young students to promote STEM diversity.

With the goal of reducing food waste, a student-developed device predicts when an avocado will be ripe

Researchers have created a treatment that when applied directly to the skin in a mouse model of psoriasis, significantly reduces levels of inflammation and symptoms of psoriasis without systemic side effects.

When scientists moved from manipulating atoms to messing with molecules, molecules started to disappear from view. Professor Kang-Kuen Ni has figured out why.

The startup company Vesigen will develop and commercialize the drug-delivery technology created in the lab of Harvard Chan School Professor Quan Lu.

Prostate cancer progresses to a more-dangerous metastatic state by resurrecting dormant molecular mechanisms that had guided the fetal development of the prostate gland but had been subsequently switched off.